PKM and coronary artery disorder: The proatherogenic role of PKM2 is supported by both clinical and experimental evidence: in patients with coronary artery disease, PKM2 is associated with increased mtROS production (37), and in mice, myeloid cell PKM2 contributes to atherogenesis (38).